We encourage you to read the next two issues of the journal „Postępów Nauk Medycznych” all of which will be devoted to hematology and bone marrow transplantation. In the last few years we have witnessed the great progress in the knowledge and understanding of pathogenetic mechanisms of many blood cancers and what directly related- the development of new therapeutic options.

I wish to draw your attention for the original paper presenting the results of AHSCT for T-cell lymphoma. The authors collected large group of patients suffering from this rare, poor prognosed lymphoma. The results are encouraging with the estimated 3-year survival of almost 80%.